The Beauty Health Company Statistics
Total Valuation
SKIN has a market cap or net worth of $249.85 million. The enterprise value is $416.58 million.
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025, after market close.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SKIN has 126.83 million shares outstanding. The number of shares has decreased by -1.73% in one year.
| Current Share Class | 126.83M |
| Shares Outstanding | 126.83M |
| Shares Change (YoY) | -1.73% |
| Shares Change (QoQ) | +12.16% |
| Owned by Insiders (%) | 9.39% |
| Owned by Institutions (%) | 60.04% |
| Float | 81.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 25.49 |
| PS Ratio | 0.79 |
| Forward PS | 0.82 |
| PB Ratio | 3.37 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.37 |
| P/OCF Ratio | 6.34 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 10.62 |
Financial Position
The company has a current ratio of 5.15, with a Debt / Equity ratio of 5.09.
| Current Ratio | 5.15 |
| Quick Ratio | 3.99 |
| Debt / Equity | 5.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | 9.61 |
| Interest Coverage | -3.75 |
Financial Efficiency
Return on equity (ROE) is -26.54% and return on invested capital (ROIC) is -4.99%.
| Return on Equity (ROE) | -26.54% |
| Return on Assets (ROA) | -4.45% |
| Return on Invested Capital (ROIC) | -4.99% |
| Return on Capital Employed (ROCE) | -9.68% |
| Revenue Per Employee | $403,204 |
| Profits Per Employee | -$24,714 |
| Employee Count | 769 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 1.75 |
Taxes
In the past 12 months, SKIN has paid $459,000 in taxes.
| Income Tax | 459,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.24% in the last 52 weeks. The beta is 1.23, so SKIN's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | +49.24% |
| 50-Day Moving Average | 2.04 |
| 200-Day Moving Average | 1.65 |
| Relative Strength Index (RSI) | 40.82 |
| Average Volume (20 Days) | 1,109,712 |
Short Selling Information
The latest short interest is 16.67 million, so 13.14% of the outstanding shares have been sold short.
| Short Interest | 16.67M |
| Short Previous Month | 15.59M |
| Short % of Shares Out | 13.14% |
| Short % of Float | 20.44% |
| Short Ratio (days to cover) | 17.57 |
Income Statement
In the last 12 months, SKIN had revenue of $310.06 million and -$19.01 million in losses. Loss per share was -$0.22.
| Revenue | 310.06M |
| Gross Profit | 190.69M |
| Operating Income | -43.40M |
| Pretax Income | -18.55M |
| Net Income | -19.01M |
| EBITDA | -15.72M |
| EBIT | -43.40M |
| Loss Per Share | -$0.22 |
Full Income StatementBalance Sheet
The company has $210.00 million in cash and $376.73 million in debt, giving a net cash position of -$166.73 million or -$1.31 per share.
| Cash & Cash Equivalents | 210.00M |
| Total Debt | 376.73M |
| Net Cash | -166.73M |
| Net Cash Per Share | -$1.31 |
| Equity (Book Value) | 74.00M |
| Book Value Per Share | 0.58 |
| Working Capital | 246.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $39.43 million and capital expenditures -$215,000, giving a free cash flow of $39.21 million.
| Operating Cash Flow | 39.43M |
| Capital Expenditures | -215,000 |
| Free Cash Flow | 39.21M |
| FCF Per Share | $0.31 |
Full Cash Flow StatementMargins
Gross margin is 61.50%, with operating and profit margins of -14.00% and -6.13%.
| Gross Margin | 61.50% |
| Operating Margin | -14.00% |
| Pretax Margin | -5.98% |
| Profit Margin | -6.13% |
| EBITDA Margin | -5.07% |
| EBIT Margin | -14.00% |
| FCF Margin | 12.65% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.73% |
| Shareholder Yield | 1.73% |
| Earnings Yield | -7.61% |
| FCF Yield | 15.70% |
Analyst Forecast
The average price target for SKIN is $2.42, which is 22.84% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.42 |
| Price Target Difference | 22.84% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 2.45% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SKIN has an Altman Z-Score of -0.2 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.2 |
| Piotroski F-Score | 5 |
